Literature DB >> 9630948

Vaccine R&D success rates and development times.

M M Struck1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 9630948     DOI： 10.1038/nbt0596-591

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

1.  Setting prices for new vaccines (in advance).

Authors:  Thomas G McGuire
Journal:  Int J Health Care Finance Econ       Date:  2003-09

Review 2.  Research and development of new vaccines against infectious diseases.

Authors:  Marie Paule Kieny; Jean-Louis Excler; Marc Girard
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

3.  Assembling a global vaccine development pipeline for infectious diseases in the developing world.

Authors:  Irina Serdobova; Marie-Paule Kieny
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

Review 4.  Emerging respiratory viruses: challenges and vaccine strategies.

Authors:  Laura Gillim-Ross; Kanta Subbarao
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 5.  Accelerating next-generation vaccine development for global disease prevention.

Authors:  Wayne C Koff; Dennis R Burton; Philip R Johnson; Bruce D Walker; Charles R King; Gary J Nabel; Rafi Ahmed; Maharaj K Bhan; Stanley A Plotkin
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

Review 6.  Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.

Authors:  Rianna Stefanakis; Andrew S Robertson; Elizabeth L Ponder; Melinda Moree
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

Review 7.  Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Authors:  Sreenivas Gannavaram; Ranadhir Dey; Kumar Avishek; Angamuthu Selvapandiyan; Poonam Salotra; Hira L Nakhasi
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

8.  Risk in vaccine research and development quantified.

Authors:  Esther S Pronker; Tamar C Weenen; Harry Commandeur; Eric H J H M Claassen; Albertus D M E Osterhaus
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.

Authors:  Dimitrios Gouglas; Tung Thanh Le; Klara Henderson; Aristidis Kaloudis; Trygve Danielsen; Nicholas Caspersen Hammersland; James M Robinson; Penny M Heaton; John-Arne Røttingen
Journal:  Lancet Glob Health       Date:  2018-10-18       Impact factor: 26.763

10.  Infectious diseases know no borders: a plea for more collaboration between researchers in human and veterinary vaccines.

Authors:  Bernard A M Van der Zeijst
Journal:  Vet J       Date:  2008-04-11       Impact factor: 2.688
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.